Table 2. Univariate and multivariate analysis of different prognostic factors for 5-year survival in patients with NSCLC.
Varible | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | P | 95% CI | HR | P | 95% CI | |
ROR2 expression | 3.113 | <0.001* | 2.146–4.517 | 2.716 | <0.001* | 1.698–4.345 |
High vs low | ||||||
Wnt5a expression | 2.500 | <0.001* | 1.759–3.553 | 1.774 | 0.003* | 1.221–2.576 |
High vs low | ||||||
ROR2/Wnt5a expression | 1.403 | 0.001* | 1.158–1.701 | 0.924 | 0.569 | 0.704–1.213 |
Both positive vs one positive vs both negative | ||||||
Age(years) | 1.040 | 0.830 | 0.730–1.481 | |||
≤ 60 vs > 60 | ||||||
Gender | 0.931 | 0.730 | 0.621–1.396 | |||
Male vs female | ||||||
Differentiation | 1.015 | 0.959 | 0.580–1.775 | |||
Well and moderate vs poor | ||||||
Histological type | 1.157 | 0.149 | 0.949–1.411 | |||
Sq vs Ad vs others | ||||||
T | 1.361 | 0.040* | 1.015–1.827 | |||
Tis+T1 vs T2 vs T3+T4 | ||||||
N | 1.448 | <0.001* | 1.183–1.773 | |||
N0 vs N1 vs N2 | ||||||
TNM stage | 1.553 | <0.001* | 1.256–1.919 | 1.410 | 0.002* | 1.133–1.755 |
0-Ivs II vs III-IV |
P < 0.05. TNM stage contains T stage and N stage, therefore, they were not included in the multivariate analysis.